Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Ryan White Part A-F Awards Announced for FY21
From the HRSA HIV/AIDS Bureau Update: Special Bulletin - 10/5/21
News Article updated on 10/06/2021 -
Office Hours: A New TA Platform for Data Support
From the DISQ Listserv - Dear RWHAP community
News Article updated on 09/10/2021 -
Rapid ART: An Essential Strategy for Ending the HIV Epidemic
What HIV care providers can do to create a rapid ART program to get HIV clients on treatment the same day as a diagnosis.Resource updated 09/19/2023
-
Rapid ART Playbook Outlines Steps to Implementation
Guide on implementing rapid ART the administration of antiretroviral therapy (ART) as quickly as possible and ideally on the same day as an HIV diagnosis/clinic visit.Blog updated 03/03/2022
-
TAP-in EHE Webinar Series
Recordings of the TAP-in webinars on topics critical to the Ending the HIV Epidemic Initiative.Resource updated 05/23/2023
-
RWHAP Part C and D Stakeholders Webinar - October 2021
Session covered program updates and trauma-informed care.Resource updated 01/10/2024
-
Needs Assessment Tool Series: Focus Groups
-
HRSA Revises RWHAP Policy Notice on Eligibility Determinations
In October 2021, HRSA's HIV/AIDS Bureau revised its client eligibility and recertification policy for the Ryan White HIV/AIDS Program.
News Article updated on 11/02/2021 -
HRSA Releases New Fact Sheets on RWHAP Clients
Ten fact sheets on client populations getting care from the Ryan White HIV/AIDS Program (RWHAP) a
News Article updated on 06/30/2021 -
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
RWHAP Part C and D Stakeholders Webinar - July 2021
Session covered program updates and Centering Care for Women, Children, and Adolescents across the HIV Care Continuum.Resource updated 01/10/2024
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024
-
Transgender Women Engagement and Entry to Care (T.W.E.E.T): E2i
T.W.E.E.T. aims to engage transgender women in HIV care by combining weekly peer-based education and discussion groups, leadership training, community building, and the provision of supportive services. Three sites implemented T.W.E.E.T. as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients had improved outcomes across the HIV care continuum 12 months after enrollment in T.W.E.E.T.Resource from the RWHAP Best Practices Compilation updated on 02/09/2024
-
Hepatitis C Screening and Treatment Expansion
The HIV clinic at Washington University integrated comprehensive hepatitis C virus (HCV) screening and treatment into its care model. Chronic HCV is a “silent” infection as it damages the liver over time, often without symptoms. Early treatment of HCV is particularly important among people with HIV, as HIV accelerates HCV’s progression. Of the 1,711 clients served at the clinic each year, 174 had a detectable HCV viral load. These clients received integrated clinical and support services to reduce barriers to ongoing HCV care engagement.Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
-
Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Review of fact sheet on different coverage and cost-sharing considerations for LAI ART across public and private payers.Blog updated 12/22/2022
-
RWHAP Part C and D Stakeholders Webinar - April 2022
Session covered program updates and program income (current practices from the field).Resource updated 01/10/2024